反応式
Cl.[CH3:2][O:3][C:4](=[O:10])[C@@H:5]([CH:7]([CH3:9])[CH3:8])[NH2:6].C1C=CC2N(O)N=NC=2C=1.CCN=C=NCCCN(C)C.[C:32]([NH:39][C@H:40]([C:49](O)=[O:50])[CH2:41][CH2:42][C:43]1[CH:48]=[CH:47][CH:46]=[CH:45][CH:44]=1)([O:34][C:35]([CH3:38])([CH3:37])[CH3:36])=[O:33].CN1CCOCC1>CN(C=O)C>[CH3:2][O:3][C:4](=[O:10])[CH:5]([NH:6][C:49](=[O:50])[CH:40]([NH:39][C:32]([O:34][C:35]([CH3:37])([CH3:36])[CH3:38])=[O:33])[CH2:41][CH2:42][C:43]1[CH:48]=[CH:47][CH:46]=[CH:45][CH:44]=1)[CH:7]([CH3:9])[CH3:8]参加物
7
反応物 5
生成物 1
試薬・触媒・溶媒 1
実験手順
To an ice-cooled solution of D-valine methyl ester hydrochloride (1000 mg, 3.58 mmol) and HOBt (in DMF (14 mL) was added EDCI (755 mg, 3.94 mmol). After the mixture was stirred for 30 min, N-boc-L-homophenylalanine (600 mg, 3.58 mmol) and N-methylmorpholine (1 mL, 8.95 mmol) were added. The mixture was warmed to room temperature and stirred overnight. The solvent was removed and the residue was partitioned between water and EtOAc. The aqueous layer was extracted with EtOAc and the combined organic phases were dried over anhydrous Na2SO4. After concentration under reduced pressure, the crude title compound (2000 mg) was obtained and used in the next step without further purification.
後処理
- stirringstirred overnight
- customThe solvent was removed
- customthe residue was partitioned between water and EtOAc
- extractionThe aqueous layer was extracted with EtOAc
- dry with materialthe combined organic phases were dried over anhydrous Na2SO4
- concentrationAfter concentration under reduced pressure
出典と根拠
- ORDレコード
- ord-5fb008c1333246cdb0cbc165b6a859a0
- 出典データセット
- uspto-grants-2011_09
- 特許番号
- US08022092B2
関連ノート
読み込み中…